{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-24-001870","form_type":"8-K","ticker":null,"cik":"0001617765","company_name":"EVOME MEDICAL TECHNOLOGIES INC.","filed_at":"2024-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.825876+00:00","generated_at":"2026-06-06T09:56:40.334737+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Evome Medical CFO resigns; reduces acquisition debt by $535K, appoints interim CFO","bullets":["CFO Natalia Vakhitova resigned Jan 22, 2024; no disagreement stated. Cherine Pottinger-Harris appointed interim CFO effective Jan 30.","Sold Arrowhead Medical, reducing acquisition bank debt by $535,093; intercompany debt reduced $209,171.","Promoted Carmine Tronolone to GM of Biodex Production; Bill Hauer appointed VP Marketing & Sales.","Preparing to launch SpaceTek Knee (co-developed with NASA) and Reactive Step Trainer in 2024.","Granted 460,000 stock options to three executives, vesting over 3 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-24-001870","json":"https://secwatch.observer/filing/0001062993-24-001870.json","markdown":"https://secwatch.observer/filing/0001062993-24-001870.md","text":"https://secwatch.observer/filing/0001062993-24-001870.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324001870/0001062993-24-001870-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324001870/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T09:56:40.334737+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d012be2f26","claim":"Cherine Pottinger-Harris was appointed as Principal Accounting Officer and interim Chief Financial Officer at EVOME MEDICAL TECHNOLOGIES INC..","evidence_excerpt":"On January 30, 2024, the Board appointed Cherine Pottinger-Harris as the Company's Principal Accounting Officer and interim Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324001870/0001062993-24-001870-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer and interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"f148df6a9c","claim":"Natalia Vakhitova resigned as Principal Accounting Officer and Chief Financial Officer at EVOME MEDICAL TECHNOLOGIES INC..","evidence_excerpt":"On January 22, 2024, Natalia Vakhitova notified the Board of Directors of Evome Medical Technologies Inc. (the \"Company\") of her intention to resign as the Company's Principal Accounting Officer and Chief Financial Officer effective on January 22, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299324001870/0001062993-24-001870-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Principal Accounting Officer and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}